Richard Mountfield
Consigliere Generale presso CONSTELLATION PHARMACEUTICALS, INC.
Posizioni attive di Richard Mountfield
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Consigliere Generale | - | - |
| AURA BIOSCIENCES, INC. | Consigliere Generale | - | - |
Storia della carriera di Richard Mountfield
Precedenti posizioni note di Richard Mountfield
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Consigliere Generale | - | - |
| CELYAD ONCOLOGY SA | Consigliere Generale | 03/02/2016 | - |
Formazione di Richard Mountfield
| University of Aberystwyth | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Belgio | 2 |
| Regno Unito | 2 |
Posizioni
| General Counsel | 4 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Richard Mountfield
- Esperienza
